Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Kenmerken, surveillance, behandeling en uitkomsten van NAFLD-gerelateerd HCC
mei 2022 | Hepatologie, Maag-darm-leveroncologie